Cancer Breakthrough: The FDA has approved Revolution Medicines’ RASONQUE (daraxonrasib), a once-daily targeted pill for metastatic pancreatic cancer, cutting the risk of death by 60% versus standard chemotherapy—an early win for patients facing one of the UK’s toughest cancers. HIV Treatment Access: ViiV Healthcare says the FDA has approved Tivicay PD (dolutegravir) for paediatric HIV patients from birth (at least 2kg), aiming to expand age-appropriate options where early treatment is critical. NHS & Care System Pressure: The Guardian reports an NHS pensions error left a claimant wrongly told they were deceased, highlighting how fragile admin processes can hit real household finances. Assisted Dying Debate: UK bishops and a Labour MP/NHS doctor argue the assisted suicide bill lacks safeguards and comes before palliative and social care are properly funded. Public Health & Safety: UKHSA issues warnings as a parasitic stomach bug rises in England; separate coverage flags NHS advice on ibuprofen use. Health Tech & Devices: Sempresto’s smartphone-integrated epinephrine auto-injector concept wins a Red Dot Design Award, targeting the problem of people not carrying their adrenaline. Workforce & Wellbeing: A study ranks Portsmouth among the UK’s most burnt-out cities, linking burnout to hours, overtime, commuting and anxiety. Global Health Context: Flash floods in Nepal/Tibet have left dozens of Britons missing; rescue efforts continue. Health & Lifestyle Research: UK Biobank-linked findings tie flavonoid-rich diets (like citrus and apples) to lower breast cancer risk, especially for women with higher genetic susceptibility.